Keyphrases
Expression Profile
100%
Cisplatin
100%
Vinorelbine
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Hazard Ratio
77%
Non-small Cell Lung Cancer Patients
33%
Completely Resected
22%
Continuous Covariate
22%
MRNA Expression
22%
Multivariate Model
22%
Model Validation
11%
Adjuvant Therapy
11%
In Vitro Cytotoxicity
11%
Predictive Effect
11%
Adjuvant Chemotherapy
11%
Pooled Analysis
11%
Cancer-specific Survival
11%
Random Effects Model
11%
PLoS
11%
Tumor
11%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Vinorelbine
100%
Cisplatin
100%
Hazard Ratio
77%
Messenger RNA
22%
Neoplasm
11%
Biological Marker
11%
Cytotoxicity
11%
Adjuvant Therapy
11%
Prospective Study
11%
Pooled Analysis
11%
Adjuvant Chemotherapy
11%
Arm
11%
In Vitro
11%
Random Effects Model
11%
Cancer Specific Survival
11%
Neuroscience
Cisplatin
100%
Vinorelbine
100%
Messenger RNA
22%
Adjuvant Therapy
11%
Cytotoxicity
11%
In Vitro
11%
Biochemistry, Genetics and Molecular Biology
Cisplatin
100%
Messenger RNA
22%
Cytotoxicity
11%
Prospective Study
11%
Cancer Specific Survival
11%
Pharmacology, Toxicology and Pharmaceutical Science